2-Methyl-1,3-thiazole-4-carboximidamide hydrochloride

CAS: 18876-82-9

Ref. 3D-FM35793

Produktinformation

• Name: 2-Methyl-1,3-thiazole-4-carboximidamide hydrochloride
• Synonyme: Buttpark 43\57-66, 2-Methylthiazole-4-Carboxamidine Hydrochloride, 2-Methyl-1,3-thiazole-4-carboximidamideHCL

Beschreibung

2-Methyl-1,3-thiazole-4-carboximidamide hydrochloride (MTZ) is a medicine that is used to treat anemia caused by chronic kidney disease. It works by increasing the production of red blood cells in the bone marrow. In clinical trials, MTZ was found to be safe and effective for the treatment of anemia in patients with chronic kidney disease. The drug has been shown to be well tolerated by humans, and it can be given orally. The drug has also been shown to have hematological effects in humans, which may be due to its ability to activate hypoxia-inducible factor 1α and stimulate erythropoiesis through hydroxylases.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 177.66 g/mol
• Formel: C₅H₇N₃S•HCl
• Reinheit: Min. 95%